Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Bio-Path Holdings, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- 0 vs. Q4 2021
- Shares held
- 392.6K
- −57.6K (−12.8%) vs. Q4 2021
- Total value
- $1.51M
- −$189.0K (−11.1%) vs. Q4 2021
- New holders
- 4
- 0 more added
- Sold out
- 4
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $5.29K |
| Q4 2024 | 22 | $370.1K |
| Q3 2024 | 14 | $53.5K |
| Q2 2024 | 13 | $285.1K |
| Q1 2024 | 10 | $78.6K |
| Q4 2023 | 19 | $276.5K |
| Q3 2023 | 23 | $256.6K |
| Q2 2023 | 18 | $812.0K |
| Q1 2023 | 21 | $793.1K |
| Q4 2022 | 21 | $976.3K |
| Q3 2022 | 19 | $1.47M |
| Q2 2022 | 17 | $1.59M |
| Q1 2022 | 17 | $1.51M |
| Q4 2021 | 17 | $1.70M |
| Q3 2021 | 17 | $2.23M |
| Q2 2021 | 17 | $2.94M |
| Q1 2021 | 19 | $3.31M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Bio-Path Holdings, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 216,062 | $830.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 65,783 | $252.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 65,201 | $250.0K | 0.00% | −810−1.2% | Reduced |
| Northern Trust Corp | 17,744 | $69.0K | 0.00% | −355−2.0% | Reduced |
| State Street Corp | 12,133 | $47.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 10,012 | $38.0K | 0.00% | +10,012 | New |
| UBS Group AG | 3,146 | $12.0K | 0.00% | −102−3.1% | Reduced |
| Tower Research Capital LLC (TRC) | 1,222 | $5.00K | 0.00% | +1,222 | New |
| Morgan Stanley | 506 | $2.00K | 0.00% | −18,918−97.4% | Reduced |
| Captrust Financial Advisors | 250 | $1.00K | 0.00% | 00.0% | Unchanged |
| Money Concepts Capital Corp | 300 | $1.00K | 0.00% | +300 | New |
| Bank of America Corp | 22 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 44 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10 | $0 | 0.00% | −4−28.6% | Reduced |
| Crewe Advisors LLC | 70 | $0 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 69 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 20 | $0 | 0.00% | +20 | New |
| Bailard, Inc. | 0 | $0 | 0.00% | −33,521−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −15,375−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Aquire Wealth Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |